This trial will test a new treatment for chronic ulcers of the lower legs and feet to see if it is safe and effective.
2 Primary · 0 Secondary · Reporting Duration: All adverse events (AEs) and serious adverse events (SAEs) will be recorded from the time of signing of the informed consent form through Week 64.
Active Control
Experimental Treatment
81 Total Participants · 2 Treatment Groups
Primary Treatment: PalinGen Flow Amniotic Tissue Allograft · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: